How Robots Are Introducing A New Dimension To Healthcare Service Delivery

Musculoskeletal

Siemens Healthineers’s COVID-19 Antigen Self-Te...

Siemens Healthineers received Emergency Use Authorization for CLINITEST® Rapid COVID-19 Antigen Self-Test by the FDA  On December 29, 2021, Siemens Healthineers was granted Emergency Use Autho...

Jan 06, 2022

medtech-news-for-cerner-scanwell-zynex-envista-sight-sciences
Cerner, Scanwell Health and Personal Genome Diagnostics Acquisition; Zynex’s Fluid Monitoring System, CM-1500; Sight Sciences’ TearCare System; Envista’s Nobel Biocare N1 Implant System

Oracle Corporation sets to acquire Cerner Corporation  On December 20, 2021, Oracle Corporation and Cerner Corporation entered into an agreement as per which Oracle will acquire Cerner through an all-cash tender offer for approximately USD 28.3 billion in equity value.  Larry Ellison, Chairman and C...

Find More
medtech-news-for-neurent-theradaptive-hagar-fujifilm-brain-navi
Neurent Medical’s NEUROMARK; Brain Navi NaoTrac received European CE Mark approval; Theradaptive receives Breakthrough Medical Device Designation; HAGAR GWave awarded Breakthrough Device Designation; Fujifilm launches ColoAssist PRO

Neurent Medical obtains FDA Clearance for NEUROMARK™, a novel multi-point Nerve Disruption Treatment for Chronic Rhinitis   On November 18, 2021, Neurent Medical, a company working in developing treatments for chronic inflammatory sino-nasal diseases, received clearance from the Food and Drug Ad...

Find More
medtech-news-and-updates-for-abbott-ivantis-medtronic-alung-appliedvr-orthalign
Abbott’s Pacemaker System; Ivantis’s Hydrus Microstent; Medtronic’s PillCam Small Bowel 3; ALung Technologies’s Hemolung; AppliedVR’s EaseVRx; J&J to split into two companies; OrthAlign’s Lantern® launch; LumiThera’s Light-based Theranostic

J&J intends to split into two companies, separating consumer products and pharmaceutical businesses  On November 12, 2021, Johnson & Johnson announced its plans to split the Company’s Consumer Health business, forming a new publicly traded company. This will help the company create two global leaders tha...

Find More

More Views & Analysis

Bone Metastasis Market
Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is considered to be - the bone. Bone Metastasis occurs when cancerous cells from the primary tumor relocate to the bone. Although almost all cancers can spread to the bone, Bone Metastasis is most commonly observed in breast, prostat...

Find More

myasthenia-gravis-treatment-market-growth-size-therapies-forecast-and-key-companies
Exploring the Market Potential of the Upcoming Therapies for the Myasthenia Gravis

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It occurs when the communication between nerve cells and muscles is disrupted. This impairment prevents critical muscle contractions from occurring, resulting in muscle weakness. This disease is associated with antibodies directed a...

Find More

recent-pharma-news-and-updates-for-Pfizer-Forte-Biosciences- Bone-Therapeutics-Versanis-Bio-AC-Immune
Pfizer’s RSV Vaccine; Forte Biosciences’ Atopic Dermatitis Asset; Bone Therapeutics’ Osteoarthritis Programme; JandJ’s HIV Vaccine Trial; Versanis Bio $70 M Series A Financing; AC Immune’s Alzheimer’s Antibody Drug

Pfizer’s RSV Vaccine enters in the late-stage of clinical trials  As the battle to get an effective Respiratory Syncytial Virus (RSV) vaccine on the market heats up, Pfizer is launching a critical late-stage study of its experimental vaccine against a severe version of a cold virus that may cause pneumonia ...

Find More

pharma-news-and-updates-for-Ascendis-MicroTransponder-BioMarin-Zimmer-Biomet-Canary-Medical
Ascendis’s SKYTROFA; MicroTransponder’s VNS System (Vivistim); BioMarin’s Voxzogo; Zimmer-Canary’s Smart Knee Implant; COVID-19 impact on Solid Organ Transplants

FDA's Green Flag to Ascendis's Once-Weekly SKYTROFA for Treatment of Pediatric Growth Hormone Deficiency For the treatment of growth failure due to deficiency of growth hormones, the USFDA approved Ascendis Pharma's Skytrofa (lonapegsomatropin-tcgd) for children of one year and older suffering from an improper s...

Find More

leading-companies-in-the-musculoskeletal-disorders-market
Analyzing the Implication of Musculoskeletal Disorders and the Key Companies in the Therapeutics Market

As per the WHO, “worldwide approximately 1.71 billion people have a musculoskeletal condition”. Musculoskeletal Disorders consist of over 150 conditions affecting the locomotor system of individuals involving the muscles, joints, bones, and spine. Among the various Musculoskeletal Disorders, low back pain causes th...

Find More

key-companies-in-the-bone-cancer-treatment-market-
Diagnosis Delays, Ineffective Treatment Options Plaque the Bone Cancer Market Growth

Over the past few decades, the incidence and prevalence of Cancer have grown significantly which has resulted in low quality of life and the survival rate. Today, cancer is the second leading cause of death globally, as per the WHO, in 2018, nearly 9.6 million people worldwide lost their life due to cancer. Cancer ...

Find More

Autoimmune hemolytic anemia (AIHA) is a rare acquired autoimmune disease. It is caused by the dysfun.....

Find More

Neurofibromatosis is a progressive and autosomal dominant inherited disorder of the nervous system w.....

Find More

Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....

Find More

Chlamydial Infection is caused by Chlamydia species and is the most common sexually transmitted bact.....

Find More

Cell therapies now are often recommended to treat cancer in several ways, out of which CAR T-cell th.....

Find More

The pharma industry has played a crucial role in fighting against the pandemic situation by supplyin.....

Find More